Nikko Asset Management Americas, Inc. Fate Therapeutics Inc Transaction History

Nikko Asset Management Americas, Inc.

$8.64 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.86 - $23.83 $3.76 Million - $9.08 Million	-380,928 Reduced 29.56%	907,930 $9.16 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $384,884 - $659,645	18,293 Added 1.44%	1,288,858 $26.7 Million
Q2 2022 Aug 04, 2022	BUY	$17.78 - $42.39 $136,888 - $326,360	7,699 Added 0.61%	1,270,565 $29.3 Million
Q1 2022 May 06, 2022	BUY	$29.67 - $60.28 $594,082 - $1.21 Million	20,023 Added 1.61%	1,262,866 $46.5 Million
Q4 2021 Feb 08, 2022	SELL	$47.84 - $64.34 $178,299 - $239,795	-3,727 Reduced 0.3%	1,242,843 $72.2 Million
Q3 2021 Nov 09, 2021	BUY	$59.27 - $95.73 $13.1 Million - $21.2 Million	221,051 Added 21.56%	1,246,570 $72.3 Million
Q2 2021 Aug 09, 2021	BUY	$67.25 - $92.52 $31.2 Million - $42.9 Million	463,924 Added 82.61%	1,025,519 $87.3 Million
Q1 2021 May 03, 2021	BUY	$72.16 - $117.4 $1.73 Million - $2.81 Million	23,931 Added 4.45%	561,595 $46.3 Million
Q4 2020 Feb 11, 2021	BUY	$38.09 - $100.95 $1.88 Million - $4.97 Million	49,265 Added 10.09%	537,664 $48.9 Million
Q3 2020 Nov 02, 2020	SELL	$30.41 - $40.5 $1.18 Million - $1.58 Million	-38,912 Reduced 7.38%	488,399 $19.3 Million
Q2 2020 Aug 07, 2020	SELL	$20.21 - $35.23 $8.06 Million - $14 Million	-398,698 Reduced 43.06%	527,311 $17.1 Million
Q1 2020 Apr 30, 2020	BUY	$17.28 - $31.88 $1.84 Million - $3.39 Million	106,199 Added 12.95%	926,009 $20.6 Million
Q4 2019 Feb 06, 2020	SELL	$13.39 - $20.73 $276,101 - $427,452	-20,620 Reduced 2.45%	819,810 $16 Million
Q3 2019 Oct 29, 2019	BUY	$15.47 - $22.5 $5.13 Million - $7.46 Million	331,589 Added 65.17%	840,430 $13.1 Million
Q2 2019 Jul 29, 2019	BUY	$15.61 - $20.44 $7.94 Million - $10.4 Million	508,841 New	508,841 $10.3 Million

Others Institutions Holding FATE

# of Institutions

176

Shares Held

113M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$16.7 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$13.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$12.8 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$7.08 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$6.67 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $123M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account